Luminary Therapeutics

Minneapolis, MN · Founded 2019 · Privately Held (backing)

Developer a cell therapy platform designed for cancer and autoimmune diseases. Luminary Therapeutics is based in Minneapolis, MN and was founded in 2019. Its last reported valuation was $59 million in Apr 2025. It has raised $24.2 million across 6 recorded rounds; the latest was a $1.4 million seed round in Oct 2025.

Last reported valuation
$59.0M
Oct 2026
Priced at
—
Total raised
$24.2M
Last round
Seed Round
Oct 2025

Luminary Therapeutics key facts

as of Oct 2026
  • Developer a cell therapy platform designed for cancer and autoimmune diseases.
  • Luminary Therapeutics is valued at approximately $59.0M as of Oct 2026 (last reported valuation).
  • It has raised $24.2M across 6 recorded rounds; the latest was Seed Round ($1.4M) in Oct 2025.
  • Notable investors include National Institutes of Health, Lateral Capital Management, Cure Xchange Challenge, 701 Fund, Cure Experience Services — 7 tracked in total.
  • Luminary Therapeutics has filed 7 Form Ds with the SEC since 2019, most recently Jan 2025 ($5.2M sold to 49 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$59.0M

Luminary Therapeutics's last reported valuation, Apr 2025. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Luminary Therapeutics with a free account
  • ·Watch Luminary Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Luminary Therapeutics funding rounds

6 rounds
Oct 2025Seed Round$1.4MSEC filing▮
Nov 2024Early Stage VC$5.2MSEC filing▮
Sep 2022Early Stage VC$5.2MSEC filing▮
Oct 2021Seed Round$375KSEC filing▮
Jan 2021Seed Round$825KSEC filing▮

Luminary Therapeutics valuation

Luminary Therapeutics's last reported valuation was $59 million in Apr 2025. No priced round, secondary trade or fund mark has surfaced since.

How much has Luminary Therapeutics raised?

Luminary Therapeutics has raised $24.2 million across 6 recorded rounds since 2019. The largest was an $825,000 seed round in Jan 2021; the most recent was a $1.4 million seed round in Oct 2025.

Luminary Therapeutics has filed 7 Form Ds with the SEC since 2019, most recently in Jan 2025 ($5.2 million sold to 49 investors).

Luminary Therapeutics investors

7 investors are on record for Luminary Therapeutics, including National Institutes of Health, Lateral Capital Management, Cure Xchange Challenge and 701 Fund. The seed round in Oct 2025 drew 6 investors.

About Luminary Therapeutics

Developer a cell therapy platform designed for cancer and autoimmune diseases. The company's platform creates an engine that completes novel and early therapeutic discovery with the help of a pipeline for B-cell malignancies, autoimmune disorders, and solid tumors autoimmune disorders, enabling doctors to eliminate viral-based cell therapy issues.

Sector
Healthcare
HQ
Minneapolis, MN, United States
Founded
2019
Employees
8
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.